MyFinsight
Home
Blog
About
US
$172,342K
(3.20%↑ Y/Y)
FR
$7,001K
(-1.57%↓ Y/Y)
CN
$4,560K
(1425.08%↑ Y/Y)
Revenues
$183,903K
(5.44%↑ Y/Y)
Gross profit
$93,470K
(8.07%↑ Y/Y)
Cost of revenues
$90,433K
(2.85%↑ Y/Y)
Income from operations
$39,729K
(-5.82%↓ Y/Y)
Total operating
expenses
$53,741K
(21.30%↑ Y/Y)
Income before income
taxes
$38,544K
(-2.01%↓ Y/Y)
Total non-operating
income (expenses), net
-$1,185K
(58.41%↑ Y/Y)
Other income
(expenses), net
$3,187K
(110.92%↑ Y/Y)
Interest income
$2,287K
(19.05%↑ Y/Y)
Research and development
$22,164K
(10.38%↑ Y/Y)
General and
administrative
$18,242K
(30.38%↑ Y/Y)
Selling, distribution,
and marketing
$13,335K
(30.29%↑ Y/Y)
Net income
$30,348K
(-2.20%↓ Y/Y)
Income tax provision
$8,196K
(-1.31%↓ Y/Y)
Interest expense
$6,659K
(6.02%↑ Y/Y)
Back
Back
Income Statement
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (AMPH)
source: myfinsight.com